Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Molecular Plant Pathology|October 1, 2024
Autophagy plays an antiviral defence role against tomato spotted wilt orthotospovirus and is counteracted by viral effector NSsXingwang Zhang, Hao Hong, Jiaoling Yan, et al.Journal of Experimental Botany|June 11, 2021
The Sw-5b NLR nucleotide-binding domain plays a role in oligomerization, and its self-association is important for activation of cell death signalingXiaohui Zhao, Zhengqiang Chen, Qian Wu, et al.Journal of Virology|April 6, 2023
Interspecies/Intergroup Complementation of Orthotospovirus Replication and Movement through Reverse Genetics SystemsMingfeng Feng, Minglong Chen, Yulong Yuan, et al.JHEP Reports : Innovation in Hepatology|June 17, 2025
Ischemia-free liver transplantation improves long-term outcomes in a 5-year follow-up studyZehua Jia, Jiaxing Zhu, Jiayi Zhang, et al.Clinical and Translational Medicine|April 27, 2022
Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantationZhiyong Guo, Jinghong Xu, Shanzhou Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
NLRs derepress MED10b- and MED7-mediated repression of jasmonate-dependent transcription to activate immunityQian Wu, Cong Tong, Zhengqiang Chen, et al.BMJ Open|May 8, 2020
Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver diseaseChangjun Huang, Shanzhou Huang, Yunhua Tang, et al.The Lancet Regional Health. Western Pacific|September 30, 2021
Ischaemia-free liver transplantation in humans: a first-in-human trialZhiyong Guo, Qiang Zhao, Shanzhou Huang, et al.Journal of Hepatology|April 22, 2023
A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver diseaseZhiyong Guo, Qiang Zhao, Zehua Jia, et al.Pageof 8